{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T06:28:48Z","timestamp":1786343328876,"version":"build-2736575974"},"reference-count":117,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["FP-1356"],"award-info":[{"award-number":["FP-1356"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>Dopaminergic drugs represent the cornerstone in the symptomatic management of Parkinson's disease motor manifestations, although their long-term use is associated with the appearance of motor fluctuations and dyskinesias. The correlation between pulsatile plasmatic levels of dopaminergic drugs and motor complications suggested that a central continuous dopaminergic stimulation (CDS) could prevent their development. Therefore, several methods have been implemented to provide more stable plasmatic levels of dopaminergic drugs and obtain a continuous drug delivery (CDD). Nevertheless, CDD does not necessarily mean CDS, since other peripheral pharmacokinetic factors intervene before the striatal dopamine release, along with central pharmacodynamic mechanisms. Here, we provide an overview of the different pharmacological approaches taken over time to reach CDS, with limitations and questions that remain open.<\/jats:p>","DOI":"10.1177\/1877718x261431104","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T08:08:21Z","timestamp":1783670901000},"page":"864-876","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Is continuous dopaminergic delivery still a major goal to be achieved in the treatment of Parkinson's disease?"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2413-1788","authenticated-orcid":false,"given":"Giulia","family":"Di Lazzaro","sequence":"first","affiliation":[{"name":"UOC Neurology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"},{"name":"Neurology Section, Departments of Neuroscience, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9298-565X","authenticated-orcid":false,"given":"Angelo Tiziano","family":"Cimmino","sequence":"additional","affiliation":[{"name":"Neurology Section, Departments of Neuroscience, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rita","family":"Bentivoglio","sequence":"additional","affiliation":[{"name":"UOC Neurology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"},{"name":"Neurology Section, Departments of Neuroscience, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Stocchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, University San Raffaele Roma and Institute for Research and Medical Care IRCCS San Raffaele, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabresi","sequence":"additional","affiliation":[{"name":"UOC Neurology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy"},{"name":"Neurology Section, Departments of Neuroscience, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1969.00480160015001"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1970.tb02939.x"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27690"},{"key":"e_1_3_2_5_2","first-page":"38","article-title":"Motor fluctuations in levodopa treatment: clinical pharmacology","volume":"36","author":"Stocchi F","year":"1996","unstructured":"Stocchi F, Bonamartini A, Vacca L, et al. Motor fluctuations in levodopa treatment: clinical pharmacology. Eur Neurol 1996; 36: 38\u201342.","journal-title":"Eur Neurol"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.9.1131"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410140213"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)92929-6"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awf214"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)91660-6"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28215"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(199903)14:2<358::AID-MDS1025>3.0.CO;2-Q"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.2.331"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10281"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-200001000-00007"},{"key":"e_1_3_2_16_2","first-page":"1044","article-title":"Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial","volume":"61","author":"Holloway RG","year":"2004","unstructured":"Holloway RG, et al. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Arch Neurol 2004; 61: 1044\u20131053.","journal-title":"Arch Neurol"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005183422004"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21743"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00315491"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70293-X"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.6.905"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-018-1864-6"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/nn1040"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70218-0"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4306"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-025-01131-5"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13092118"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/nep3.60"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2025.1638668"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1515\/nipt-2025-0016"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2025.103150"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mocell.2025.100274"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1080\/01677063.2025.2571127"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S549893"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/syn.20759"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870130207"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(86)90783-3"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)24938-2"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.1149"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20317"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25218"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25251"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-013-1329-8"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s702-002-8236-2"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-017-1681-3"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2012.11.018"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00836-6"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27261"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00245"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25851"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2014.0184"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2025.107354"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01429-0"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15539"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20988"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23498"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.4137\/JCNSD.S5210"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70108-4"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21741"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5c00294"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.2174\/1568026619666190712210903"},{"key":"e_1_3_2_62_2","article-title":"A Review of the Recent Advances in the Pharmacological Management of Parkinson\u2019s Disease","volume":"17","author":"Li A","year":"2025","unstructured":"Li A, Cha A, Huang M, et al. A Review of the Recent Advances in the Pharmacological Management of Parkinson\u2019s Disease. Cureus 2025; 17.","journal-title":"Cureus"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.3390\/diseases13090290"},{"key":"e_1_3_2_64_2","unstructured":"Study Details | NCT04760769 | Open-label Trial in Parkinson\u2019s Disease (PD) | ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT04760769."},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23204"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.2.241"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71083-7"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809335"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25751"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25961"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-150569"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.4.1066"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0404.2002.1o174.x"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.5.1309"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00336-1"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.4703"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-023-02603-y"},{"key":"e_1_3_2_78_2","first-page":"8850","article-title":"The role of opicapone in the management of Parkinson\u2019s disease: an Italian consensus through a combined nominal group technique and Delphi approach","volume":"27","author":"Antonini A","year":"2023","unstructured":"Antonini A, et al. The role of opicapone in the management of Parkinson\u2019s disease: an Italian consensus through a combined nominal group technique and Delphi approach. Eur Rev Med Pharmacol Sci 2023; 27: 8850\u20138859.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.6_Suppl_6.S27"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22060"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29685"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2023.2679"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2013.08.017"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.514"},{"key":"e_1_3_2_85_2","first-page":"100197","article-title":"Improving levodopa delivery: IPX203, a novel extended-release carbidopa-levodopa formulation","volume":"8","author":"LeWitt P","year":"2023","unstructured":"LeWitt P, Ellenbogen A, Burdick D, et al. Improving levodopa delivery: IPX203, a novel extended-release carbidopa-levodopa formulation. Clin Park Relat Disord 2023; 8: 100197. doi: https:\/\/doi.org\/10.1016\/j.prdoa.2023.100197. PMID: 37181100; PMCID: PMC10172697.","journal-title":"Clin Park Relat Disord"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91755-2"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100720170062"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30239-4"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.13810"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26123"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2017.09.018"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.13239"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2013.02.006"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-212813"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2022.03.012"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00400-8"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-202285"},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28758"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00052-8"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1177\/08919887251335011"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-025-01179-3"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2024-334521"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-023-05377-5"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612822666160928145346"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2011.07.029"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14051080"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2018.08.004"},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94175-8"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119148"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2017.12.056"},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2017.1359862"},{"key":"e_1_3_2_112_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410270105"},{"key":"e_1_3_2_113_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25364"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22097"},{"key":"e_1_3_2_115_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pbr.2021.01.032"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2015.11.022"},{"key":"e_1_3_2_117_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2023.102548"},{"key":"e_1_3_2_118_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(25)00305-9"}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261431104","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1877718X261431104","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261431104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T05:45:07Z","timestamp":1786340707000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1877718X261431104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":117,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1177\/1877718X261431104"],"URL":"https:\/\/doi.org\/10.1177\/1877718x261431104","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]}}}